Longevity & AgingResearch PaperOpen Access

Female BAT Burns More Energy Due to PGC-1α Driving Unique Phospholipid Synthesis

Scientists uncover why female brown fat outperforms males in thermogenesis — a PGC-1α–estrogen–lipid axis exclusive to females.

Friday, May 22, 2026 0 views
Published in Nat Commun
Cross-section of brown fat cells glowing orange with dense mitochondria and intricate membrane folds under electron microscopy lighting

Summary

Brown adipose tissue (BAT) generates heat and protects against metabolic disease, and females consistently show higher BAT activity than males. This mouse study reveals why: the transcriptional coactivator PGC-1α is more highly expressed in female BAT, where it drives a sex-specific program linking estrogen signaling to de novo lipogenesis and specialized phospholipid synthesis. Female-only knockout of PGC-1α collapsed mitochondrial cristae structure, reduced thermogenic capacity, and impaired cold tolerance — effects absent in males. The key intermediary is ChREBPβ, a lipogenic transcription factor regulated by estrogen that controls synthesis of ether-linked phosphatidylethanolamine and tetra-linoleoyl cardiolipin — lipids critical for mitochondrial membrane integrity and function. These findings map a female-specific molecular circuit that may help explain women's relative metabolic advantage before menopause.

Deep Dive Audio
0:00--:--

Detailed Summary

Brown adipose tissue (BAT) burns calories as heat through uncoupling protein-1 (UCP1), and its activity is inversely associated with obesity, type 2 diabetes, and cardiovascular disease risk. Epidemiological and animal data consistently show that females have more active, more abundant BAT than males, potentially contributing to the well-documented premenopausal metabolic advantage in women. Yet the molecular mechanism has remained unclear.

This study by Takeuchi, Tsujimoto, Aoki, and colleagues at Institute of Science Tokyo and University of Tokyo used inducible, adipocyte-specific PGC-1α knockout (KO) mice in both sexes to dissect the sex-specific role of this master mitochondrial regulator. PGC-1α expression was significantly higher in female BAT than male BAT at room temperature, further diverging under cold exposure and converging under thermoneutral conditions. When PGC-1α was deleted in adipocytes, only female KO mice showed reduced rectal temperature and interscapular surface temperature during acute cold challenge, lower norepinephrine-stimulated oxygen consumption, and disrupted mitochondrial cristae architecture — defects entirely absent in male KO mice.

Mechanistically, the team found that PGC-1α deletion in female BAT selectively suppressed expression of ChREBPβ (encoded by Chrebpβ), a glucose-responsive transcription factor, along with downstream de novo lipogenesis (DNL) genes. BAT-specific knockdown of ChREBPβ in wild-type females phenocopied the mitochondrial morphology and thermogenic defects seen in female KO mice, confirming ChREBPβ as a critical effector. Lipidomics revealed that PGC-1α promotes accumulation of ether-linked phosphatidylethanolamine (ePE) and cardiolipin(18:2)₄ — a tetra-linoleoyl cardiolipin species essential for mitochondrial cristae integrity and respiratory chain efficiency — through both ChREBPβ-dependent and independent pathways.

Further experiments showed that PGC-1α amplifies estrogen receptor signaling in female BAT, increasing sensitivity to estrogen and thereby upregulating Chrebpβ and its DNL target genes. This creates a positive feedback axis: female sex hormones activate PGC-1α expression, which in turn boosts estrogen signaling, driving lipid remodeling that maintains the dense, functional cristae characteristic of female BAT. This circuit is simply absent or non-operative in male BAT.

The implications are significant. The study provides a molecular explanation for the female BAT advantage and, by extension, a potential mechanistic underpinning of the metabolic protection seen in premenopausal women. It also identifies ChREBPβ, ether-PE, and cardiolipin(18:2)₄ as potential therapeutic targets for metabolic disease, with the caveat that interventions may need to account for sex-specific biology. Limitations include the exclusively murine model, which may not fully recapitulate human BAT biology, and the use of global adipocyte-specific Cre rather than BAT-selective targeting.

Key Findings

  • Female BAT expresses significantly more PGC-1α than male BAT, amplified further by cold exposure.
  • Adipocyte-specific PGC-1α deletion impairs cold tolerance and BAT thermogenesis exclusively in female mice.
  • PGC-1α drives ChREBPβ expression in female BAT, linking estrogen signaling to de novo lipogenesis.
  • PGC-1α promotes ether-PE and cardiolipin(18:2)₄ synthesis, maintaining mitochondrial cristae integrity in females.
  • BAT-specific ChREBPβ knockdown in wild-type females phenocopies the mitochondrial and thermogenic defects of female KO mice.

Methodology

Researchers generated tamoxifen-inducible adipocyte-specific PGC-1α knockout mice (Adipoq-Cre-ERT2) in both sexes, assessed cold tolerance and NE-stimulated oxygen consumption, performed electron microscopy for mitochondrial morphology, RNA-seq, BAT-specific adeno-associated virus ChREBPβ knockdown, and comprehensive lipidomics to profile phospholipid species in BAT.

Study Limitations

All experiments were conducted in mice; human BAT has distinct characteristics and the translational relevance requires validation. The Adipoq-Cre system targets all adipocytes, not BAT exclusively, introducing potential confounding from white adipose effects. The estrogen-signaling mechanism was characterized pharmacologically and may not fully reflect physiological hormonal dynamics across the estrous cycle.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.